Companisto
Media hype & sold-out product
Online-Version view
Companisto
INVEST NOW
Hello awha hawhwa,
after exceptional media interest, PerioTrap returns for only two days one last time to Companisto. The financing round is only open until next Wednesday and will then be finally closed.

The trigger is a press release from the Fraunhofer Institute on the technology of PerioTrap, which has nationwide and international great attention – with immediate effects on demand. The microbiome toothpaste was sold out within a very short time, while thousands of interested parties and numerous media inquiries are still coming in
Many newly acquired interested parties wanted to also participate in PerioTrap after the official closing of the round. In order to meet this demand fairly and transparently, the financing round has now been re-opened once. This re-opening is limited in time and amount and represents the last participation opportunity within this round.
Read more about the current dynamics and the next steps of PerioTrap in the update from founder and CEO Pierre Tangermann.
INVEST NOW FROM EUR 250
INVESTMENT HIGHLIGHTS
Industry: BioTech
Co-financing with bmp Ventures (1 million €).
Successful market entry: Microbiome toothpaste (Consumer) and dental gel (Professional) in distribution through pharmacies and dentists.
Strong shareholder base: Fraunhofer Venture, bmp Ventures, EMS Dental (world market leader in the field of dental prophylaxis).
Large growth market: Periodontosis - 1 billion sufferers worldwide.
Spin-off of the Fraunhofer Institute: Many years of product development, research and patents.
INVEST IN PERIOTRAP NOW
Siegel Trust
Follow us
LinkedIN Facebook Instagram Youtube
Icon1
Companisto GmbH
Köpenicker Str. 154, 10997 Berlin
Managing Director: Tamo Zwinge, LL. M. and David Rhotert
Amtsgericht: Berlin Charlottenburg HRB 132811 B
VAT-ID: DE 276 014 929
Phone: +49 30 330 837 49
Email: angelclub@companisto.com
Terms and Conditions
Privacy Policy
Unsubscribe
You receive this newsletter because you have subscribed to it. You can unsubscribe at any time via the unsubscribe link.
The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
                                                           

If you want to unsubscribe from our mailing list, unsubscribe here.